EPA significantly improves anti‑EGFR targeted therapy by regulating miR‑378 expression in colorectal cancer-Reference-Cited by-同舟云学术

EPA significantly improves anti‑EGFR targeted therapy by regulating miR‑378 expression in colorectal cancer

Published:2018-09-05 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Weng Wen‑Hui¹,Leung Wai‑Hung¹,Pang Yeu²,Kuo Li‑Wei¹,Hsu Hsi‑Hsien³

Affiliation:

1. Department of Chemical Engineering and Biotechnology, Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei 10608, Taiwan, R.O.C.

2. Department of Internal Medicine, Queen Elizabeth The Queen Mother Hospital, Margate CT9 4AN, UK

3. Division of Colorectal Surgery, Department of Surgery, Mackay Memorial Hospital, Taipei 10491, Taiwan, R.O.C.

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanisms Associated with the Inhibitory Role of Long Chain n-3 PUFA in Colorectal Cancer;Integrative Cancer Therapies;2024-01

2. Revolutionizing colorectal cancer treatment: unleashing the potential of miRNAs in targeting cancer stem cells;Future Oncology;2023-11-16

3. Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy;Cell Communication and Signaling;2022-09-21

4. Correlation of Wilms’ Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer;Indian Journal of Clinical Biochemistry;2022-07-16

5. EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer;Cancers;2022-06-06